You have 9 free searches left this month | for more free features.

Tofacitinib

Showing 251 - 258 of 258

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Trial in New Haven (Tasocitinib (CP-690,550) plus Rifampin)

Completed
  • Healthy
  • Tasocitinib (CP-690,550) plus Rifampin
  • New Haven, Connecticut
    Pfizer Investigational Site
Oct 21, 2010

Healthy Trial in Singapore (CP-690,550)

Completed
  • Healthy
  • Singapore, Singapore
    Pfizer Investigational Site
Sep 13, 2010

Healthy Trial in Singapore (Tasocitinib 10 mg oral tablet, Tasocitinib 10 mg IV Infusion)

Completed
  • Healthy
  • Tasocitinib 10 mg oral tablet
  • Tasocitinib 10 mg IV Infusion
  • Singapore, Singapore
    Pfizer Investigational Site
Aug 6, 2010

Healthy Trial in Bruxelles (ethinyloestradiol (EE) and levonorgestrel (LN), CP-690,550 + ethinyloestradiol (EE) and

Completed
  • Healthy
  • ethinyloestradiol (EE) and levonorgestrel (LN), CP-690,550 + ethinyloestradiol (EE) and levonorgestrel (LN)
  • CP-690,550 + ethinyloestradiol (EE) and levonorgestrel (LN), ethinyloestradiol (EE) and levonorgestrel (LN)
  • Bruxelles, Belgium
    Pfizer Investigational Site
Aug 5, 2010

Arthritis, Rheumatoid Trial in Woburn (CP 690,550 oral solutions)

Completed
  • Arthritis, Rheumatoid
  • CP 690,550 oral solutions
  • Woburn, Massachusetts
    Pfizer Investigational Site
Jun 14, 2010

Hepatic Insufficiency Trial in South Miami (CP-690,550)

Completed
  • Hepatic Insufficiency
  • South Miami, Florida
    Pfizer Investigational Site
Feb 10, 2010

Healthy Volunteer Trial in New Haven (midazolam; CP-690,550 + midazolam, CP-690,550 + midazolam; midazolam)

Completed
  • Healthy Volunteer
  • midazolam; CP-690,550 + midazolam
  • CP-690,550 + midazolam; midazolam
  • New Haven, Connecticut
    Pfizer Investigational Site
Aug 12, 2009

Healthy Volunteers Trial in Singapore (CP- 690,550 and Tacrolimus, CP- 690,550 and Cyclosporine)

Completed
  • Healthy Volunteers
  • CP- 690,550 and Tacrolimus
  • CP- 690,550 and Cyclosporine
  • Singapore, Singapore
    Pfizer Investigational Site
Aug 12, 2009